Home/ Supplements/ Kava/ Kava Haven

Kava Haven

product on market Liquid Kava Haven Safety: 90/100
90/100

This product looks safe

  • Noble Kava: 500mg is 2.0× the Tolerable Upper Intake Level (250mg)
  • 25% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Noble Kava is the primary active ingredient, with moderate evidence supporting its use for promoting relaxation and reducing anxiety. The remaining ingredients are basic macronutrients that do not provide therapeutic benefits. Overall, the evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Noble Kava: 500mg is 2.0× the Tolerable Upper Intake Level (250mg)

Label

Product Label

Label for Kava Haven
Open Full PDF View on NIH DSLD →
Details

Label Data

1.5 fl. Oz.
Serving Size
17
Servings
Botanical
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
30 Calorie(s)
Total Carbohydrates
5 Gram(s) (2% DV)
Total Sugars
5 Gram(s)
500 mg
Exceeds UL by 2.0× (UL: 250 mg) 15 studies (A:0, B:5)

Other Ingredients

Water, Filtered Lemon Juice Concentrate White Grape Juice Lemon Extract Cardamom Extract Orange Blossom Extract Vanilla Extract Ginger Extract Natural Flavors Potassium Sorbate Sodium Benzoate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Formulation Notes

Zero proof Kava-infused non-alcoholic spirit

Kava-infused non-alcoholic spirit

Metadata

Product Details

DSLD Entry Date2025-08-22
Product TypeBotanical
FormLiquid
DSLD ID332977
Data Updated2026-04-11
Research

Research Evidence

19
Research Sources
48
Avg Quality
8
Rct
5
Systematic Review
4
Meta Analysis
2
Clinical Trial
B Kava extract for treating anxiety
Meta Analysis The Cochrane database of systematic reviews 2003 PubMed
B Kava for Generalized Anxiety Disorder: A Review of Current Evidence
Meta Analysis Journal of alternative and complementary medicine (New York, N.Y.) 2018 PubMed DOI
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2001 PubMed
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2002 PubMed
B The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials
Systematic Review Complementary therapies in clinical practice 2018 PubMed DOI
C Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Rct The Australian and New Zealand journal of psychiatry 2020 PubMed DOI
C Kava and St. John's Wort: current evidence for use in mood and anxiety disorders
Systematic Review Journal of alternative and complementary medicine (New York, N.Y.) 2009 PubMed DOI
C Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.
Rct Nutrients PubMed DOI
C The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
Meta Analysis Annals of internal medicine 2002 PubMed
C Efficacy of kava extract for treating anxiety: systematic review and meta-analysis
Meta Analysis Journal of clinical psychopharmacology 2000 PubMed
View all evidence for Kava →
Compare

Similar Products

View all Kava products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.